Literature DB >> 8255357

Fusogenic properties of Sendai virosome envelopes in rat brain preparations.

C M de Fiebre1, S O Bryant, D Notabartolo, P Wu, E M Meyer.   

Abstract

Sendai virosomes were characterized with respect to their ability to bind to, fuse with, and introduce substances into several rat brain preparations. Encapsulation efficiency for Sendai virosomes was enhanced but binding to cerebral cortical P2 preparations was attenuated by addition of bovine brain phosphatidylcholine during reconstitution. A higher percentage of Sendai virosomes than phosphatidylcholine liposomes appeared to bind to, fuse with and subsequently deliver [14C]sucrose into osmotically labile pools of the P2 preparation. Fusogenic activity was estimated by measuring dequenching of fluorescently labelled N-NBD-phosphatidylethanolamine. More virosomally encapsulated [14C]sucrose was bound to the P2 fraction than introduced into osmotically labile organelles, and the fraction of vesicles undergoing fusion was intermediate between these two values. Non-encapsulated [14C]sucrose did not bind to and was not taken up by the P2 fraction in a quantifiable manner. Virosomal envelopes also bound to primary cultures of rat brain neurons and glia in an apparently saturable manner. Addition of increasing amounts of the adenoassociated virus-derived vector pJDT95 increased encapsulation efficiency, and virosomes reconstituted in the presence of 60 micrograms DNA retained most of their binding activity (5.4% of total label) compared to those containing [14C]sucrose alone (8.4%). These data indicate that Sendai virosomes may be useful in the delivery of substances into brain-derived tissues, potentially for the modulation of gene expression and neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255357     DOI: 10.1007/bf00966689

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  Possible mechanisms involved in the release and modulation of release of neuroactive agents.

Authors:  J R Cooper; E M Meyer
Journal:  Neurochem Int       Date:  1984       Impact factor: 3.921

2.  The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides.

Authors:  Y Kaneda; T Uchida; J Kim; M Ishiura; Y Okada
Journal:  Exp Cell Res       Date:  1987-11       Impact factor: 3.905

3.  Fusion between Sendai virus envelopes and biological membranes. The use of fluorescent probes for quantitative estimation of virus-membrane fusion.

Authors:  N Chejanovsky; A Loyter
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

4.  Converting Sendai virus into a specific fusogen whose cell target can be selected.

Authors:  O Martinez; J Kimura; C Henry; L Wofsy
Journal:  Exp Cell Res       Date:  1986-09       Impact factor: 3.905

5.  Improved methods for the delivery of liposome-sequestered RNA into eucaryotic cells.

Authors:  D Lavelle; W B Paxton; D I Blaustein; M J Ostro; D Giacomoni
Journal:  Arch Biochem Biophys       Date:  1982-05       Impact factor: 4.013

6.  Evidence for different receptor sites in mouse spleen cells for the Sendai virus hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins.

Authors:  E Peterhans; T Baechi; J Yewdell
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

7.  Activation of Sendai virus infectivity by an enzyme in chicken amniotic fluid.

Authors:  G Appleyard; G B Davis
Journal:  J Gen Virol       Date:  1983-04       Impact factor: 3.891

8.  Pharmacological and ionic characterizations of the muscarinic receptors modulating [3H]acetylcholine release from rat cortical synaptosomes.

Authors:  E M Meyer; D H Otero
Journal:  J Neurosci       Date:  1985-05       Impact factor: 6.167

9.  Targeting of loaded Sendai virus envelopes by covalently attached insulin molecules to virus receptor-depleted cells: fusion-mediated microinjection of ricin A and simian virus 40 DNA.

Authors:  A G Gitman; A Graessmann; A Loyter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Evaluation of reconstituted Sendai virus envelopes as intra-articular drug vectors: effects on normal and experimentally arthritic rabbit knee joints.

Authors:  R T Earl; I M Hunneyball; E E Billett; R J Mayer
Journal:  J Pharm Pharmacol       Date:  1988-03       Impact factor: 3.765

View more
  2 in total

1.  NGF gene expression in dividing and non-dividing cells from AAV-derived constructs.

Authors:  S Wang; W J Millard; E M Meyer
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

2.  Differential adenoassociated virus vector-driven expression of a neuropeptide Y gene in primary rat brain astroglial cultures after transfection with Sendai virosomes versus Lipofectin.

Authors:  C M de Fiebre; P Wu; D Notabartolo; W J Millard; E M Meyer
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.